A high-fat diet impairs cardiac high-energy phosphate metabolism and cognitive function in healthy human subjects

American Journal of Clinical Nutrition

Volumn 93, Issue 4, 2011, Pages 748-755

  Holloway, Cameron J ^a,b   Cochlin, Lowri E ^a,b   Emmanuel, Yaso ^a,b   Murray, Andrew ^a   Codreanu, Ion ^a,b   Edwards, Lindsay M ^a   Szmigielski, Cezary ^b   Tyler, Damian J ^a,b   Knight, Nicholas S ^a   Saxby, Brian K ^c   Lambert, Bridget ^d   Thompson, Campbell ^a   Neubauer, Stefan ^b   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Cognitive Drug Research Ltd ^*  (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE PHOSPHATE; FATTY ACID;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATTENTION DISTURBANCE; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; HEART FUNCTION; HEART MUSCLE METABOLISM; HIGH ENERGY PHOSPHATE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; LOW CARBOHYDRATE DIET; MALE; METABOLITE; MOOD DISORDER; PHOSPHATE METABOLISM; RESPIRATORY QUOTIENT; VELOCITY;

ADENOSINE TRIPHOSPHATE; ADULT; AFFECT; ATTENTION; COGNITION; CROSS-OVER STUDIES; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DIETARY FATS; ECHOCARDIOGRAPHY; ENERGY INTAKE; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE; REFERENCE VALUES; YOUNG ADULT;

EID: 79953214035     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.002758     Document Type: Article

References (59)

1. Atkins RC. Dr Atkins new diet revolution. London, United Kingdom: Vermillion, 2003.
2. Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv Pediatr 1997;44:297-329.
3. Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2005;64:728-30. (Pubitemid 40261909)
4. Law M. Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. Am J Clin Nutr 2000;72: 1291S-6S.
5. Marshall JA, Bessesen DH, Hamman RF. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia 1997;40:430-8. (Pubitemid 27132613)
6. Foo SY, Heller ER, Wykrzykowska J, et al. Vascular effects of a low-carbohydrate high-protein diet. Proc Natl Acad Sci USA 2009;106:15418-23.
7. Bisschop PH, de Metz J, Ackermans MT, et al. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001;73:554-9. (Pubitemid 32176506)
8. Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997;46:1768-74. (Pubitemid 27456409)
9. Murray AJ, Knight NS, Cochlin LE, et al. Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. FASEB J 2009;23:4353-60.
10. Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem 2000;275:30749-52.
11. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet 2004;364:1786-8. (Pubitemid 39488064)
12. Boss O, Hagen T, Lowell BB. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000;49:143-56. (Pubitemid 30070991)
13. Pressman BC, Lardy HA. Effect of surface active agents on the latent ATPase of mitochondria. Biochim Biophys Acta 1956;21:458-66.
14. Echtay KS, Winkler E, Frischmuth K, Klingenberg M. Uncoupling proteins 2 and 3 are highly active H+ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc Natl Acad Sci USA 2001;98:1416-21. (Pubitemid 32165513)
15. Scheuermann-Freestone M, Madsen PL, Manners D, et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003;107:3040-6. (Pubitemid 36758977)
16. Zhang J, McKeown RE, Muldoon MF, Tang S. Cognitive performance is associated with macronutrient intake in healthy young and middle-aged adults. Nutr Neurosci 2006;9:179-87. (Pubitemid 44869163)
17. Ortega RM, Requejo AM, Andres P, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 1997;66:803-9. (Pubitemid 27415562)
18. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Longitudinal study of the effect of apolipoprotein e4 allele on the association between education and cognitive decline in elderly men. BMJ 1997;314:34-5. (Pubitemid 27023234)
19. Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001;31:290-5. (Pubitemid 32734932)
20. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005;28:726-35. (Pubitemid 40315341)
21. Tyler DJ, Emmanuel Y, Cochlin LE, et al. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T. NMR Biomed 2009;22:405-13.
22. Hudsmith LE, Petersen SE, Tyler DJ, et al. Determination of cardiac volumes and mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: a validation study. J Magn Reson Imaging 2006;24:312-8. (Pubitemid 44188556)
23. Petersen SE, Jung BA, Wiesmann F, et al. Myocardial tissue phase mapping with cine phase-contrast mr imaging: regional wall motion analysis in healthy volunteers. Radiology 2006;238:816-26. (Pubitemid 43289912)
24. Robson MD, Tyler DJ, Neubauer S. Ultrashort TE chemical shift imaging (UTE-CSI). Magn Reson Med 2005;53:267-74. (Pubitemid 40171040)
25. Bottomley PA, Hardy CJ. Proton Overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T. Magn Reson Med 1992;24:384-90.
26. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001;31:269-86. (Pubitemid 32378728)
27. Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-8.
28. Ernst RR, Bodenhausen G, Wokaun A. Principles of nuclear magnetic resonance in one and two dimensions. Oxford, United Kingdom: Oxford University Press, 2004.
29. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 2000;152:353-61.
30. Opie LH. Heart physiology: from cell to circulation. Philadelphia, PA: Lippincott, Williams & Wilkins, 2004.
31. Wisneski JA, Gertz EW, Neese RA, Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987;79:359-66. (Pubitemid 17009666)
32. Vik-Mo H, Mjos OD. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury. Am J Cardiol 1981;48:361-5. (Pubitemid 11019075)
33. Ray J, Noll F, Daut J, Hanley PJ. Long-chain fatty acids increase basal metabolism and depolarize mitochondria in cardiac muscle cells. Am J Physiol Heart Circ Physiol 2002;282:H1495-501.
34. Van der Lee KAJM, Willemsen PHM, Samec S, et al. Fasting-induced changes in the expression of genes controlling substrate metabolism in the rat heart. J Lipid Res 2001;42:1752-8. (Pubitemid 33116706)
35. Young ME, Patil S, Ying J, et al. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor α in the adult rodent heart. FASEB J 2001;15:833-45. (Pubitemid 32246002)
36. Murray AJ, Panagia M, Hauton D, Gibbons GF, Clarke K. Plasma free fatty acids and peroxisome proliferator-activated receptor α in the control of myocardial uncoupling protein levels. Diabetes 2005;54:3496-502. (Pubitemid 43334341)
37. Mjos OD, Kjekshus J. Increased local metabolic rate by free fatty acids in the intact dog heart. Scand J Clin Lab Invest 1971;28:389-91.
38. Simkins, S. (1937) Dinitrophenol and desiccated thyroid in the treatment of obesity. JAMA 1937;108:2110-7.
39. Aasum E, Belke DD, Severson DL, et al. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator. Am J Physiol Heart Circ Physiol 2002;283:H949-57.
40. Boudina S, Sena S, Theobald H, et al. Mitochondrial energetics in the heart in obesity related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007;56:2457-66. (Pubitemid 47523253)
41. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 2007;356:1140-51. (Pubitemid 46425598)
42. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-6. (Pubitemid 27425822)
43. Paolisso G, Gambardella A, Galzerano D, et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 1994;43:174-9. (Pubitemid 24061849)
44. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003;42:328-35. (Pubitemid 36851426)
45. Metzler B, Schocke MF, Steinboeck P, et al. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 2002;4:493-502. (Pubitemid 36083960)
46. Shivu GN, Phan TT, Abozguia K, et al. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation 2010;121:1209-15.
47. Jung WI, Hoess T, Bunse M, et al. Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Circulation 2000;101:E121.
48. Hammer S, van der Meer RW, Lamb HJ, et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008;93:497-503. (Pubitemid 351240822)
49. Leichman JG, Aguilar D, King TM, Vlada A, Reyes M, Taegtmeyer H. Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. Am J Clin Nutr 2006;84:336-41. (Pubitemid 44699142)
50. Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008;52:1006-12.
51. Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol 2003;2:16.
52. Cacciatore F, Abete P, Ferrara N, et al. Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc 1998;46:1343-8. (Pubitemid 28511873)
53. Alvarez EO, Beauquis J, Revsin Y, et al. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2009;198:224-30.
54. Lamport DJ, Lawton CL, Mansfield MW, Dye L. Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 2009;33:394-413.
55. Ferguson SC, Blane A, Wardlaw J, et al. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 2005;28:1431-7. (Pubitemid 40756709)
56. Wing RR, Vazquez JA, Ryan CM. Cognitive effects of ketogenic weight-reducing diets. Int J Obes Relat Metab Disord 1995;19:811-6.
57. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008;9:23-31.
58. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 2004;55:576-80. (Pubitemid 38391976)
59. Chen TY, Smith W, Rosenstock JL, Lessnau KD. A life-threatening complication of Atkins diet. Lancet 2006;367:958.